High materiality9/10
Precision BioSciences initiated with an Outperform at Oppenheimer
Why it may matterVerify against the original reporting
Bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Oppenheimer initiated DTIL with an Outperform rating; target price $20; current price $6.77.
- Oppenheimer initiates DTIL with Outperform; target $20; current $6.77.
Key facts
- 01
Target: $20
- 02
Posted price: $6.77
- 03
Analyst firm: Oppenheimer
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.